You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nasopharyngeal Neoplasms

Showing 1 - 25 of 1,712
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Tumors Trial (The combination treatment of anlotinib, penpulimab and capecitabine.)

Not yet recruiting
  • Nasopharyngeal Neoplasms
  • The combination treatment of anlotinib, penpulimab and capecitabine.
  • (no location specified)
Apr 10, 2023

Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (Nimotuzumab, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 3, 2022

Nasopharyngeal Cancer Trial in Shanghai (Toripalimab, Induction chemo and concurrent chemoradiation)

Recruiting
  • Nasopharyngeal Cancer
  • Toripalimab
  • Induction chemotherapy and concurrent chemoradiation
  • Shanghai, Shanghai, China
    Fudan Universtiy Shanghai Cancer Centre
Nov 25, 2022

Cervical Cancer, Nasopharyngeal Cancer, Chemo-induced Nausea and Vomiting Trial in Shantou (Fosaprepitant, tropisetron,

Recruiting
  • Cervical Cancer
  • +4 more
  • Shantou, Guangdong, China
    Cancer Hospital of Shantou University Medical College
Sep 29, 2022

Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Singapore (FDG-PET, Galium-68 DOTATATE)

Recruiting
  • Nasopharyngeal Cancer
  • Epstein-Barr Virus Related Carcinoma
  • FDG-PET
  • Galium-68 DOTATATE
  • Singapore, Singapore
    National Cancer Centre Singapore
Oct 13, 2022

Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (gemcitabine and cisplatin,

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • gemcitabine and cisplatin
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 4, 2022

Nasopharyngeal Tumors Trial in China (Sintilimab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Nasopharyngeal Neoplasms
  • Foshan, Guangdong, China
  • +8 more
Oct 6, 2022

Nasopharyngeal Carcinoma Trial in Brescia (Pembrolizumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Brescia, Italy
    Asst Degli Spedali Civili Di Brescia
Mar 29, 2022

Intrinsic Radiation Sensitivity in Cancer Patients

Recruiting
  • Nasopharyngeal Cancer
  • +2 more
    • Singapore, Singapore
      National Cancer Center Singapore
    Dec 1, 2022

    Nasopharyngeal Carcinoma, Nasopharyngeal Cancer Trial in Shanghai (Fluzoparib and Camrelizumab)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Nasopharyngeal Cancer
    • Fluzoparib and Camrelizumab
    • Shanghai, Shanghai, China
      Fudan Universtiy Shanghai Cancer Centre
    Jun 4, 2022

    Metastatic Nasopharyngeal Cancer Trial in Shenzhen (Radiotherapy)

    Recruiting
    • Metastatic Nasopharyngeal Cancer
    • Radiotherapy
    • Shenzhen, China
      National Cancer Center/National Clinical Research Center for Can
    May 21, 2022

    Nasopharyngeal Cancer Trial in Jakarta (Auto-Dendritic Adjuvant Therapy, Allo-Dendritic-Secretome Adjuvant Therapy)

    Not yet recruiting
    • Nasopharyngeal Cancer
    • Auto-Dendritic Adjuvant Therapy
    • Allo-Dendritic-Secretome Adjuvant Therapy
    • Jakarta, Indonesia
      PT Prodia StemCell Indonesia
    Mar 1, 2022

    Nasopharyngeal Tumors Trial in China (Camrelizumab)

    Recruiting
    • Nasopharyngeal Neoplasms
    • Foshan, Guangdong, China
    • +10 more
    May 3, 2022

    Nasopharyngeal Cancer Trial in Singapore (cisplatin and gemcitabine, induction chemo cisplatin, gemcitabine, bevacizumab and

    Not yet recruiting
    • Nasopharyngeal Cancer
    • cisplatin and gemcitabine
    • induction chemotherapy cisplatin, gemcitabine, bevacizumab and pembrolizumab.
    • Singapore, Singapore
      National University Hospital
    Mar 22, 2022

    Nasopharyngeal Carcinoma, Nasopharyngeal Cancer, Nasopharyngeal Tumors Trial in Germany (drug, radiation, procedure, behavioral)

    Recruiting
    • Nasopharyngeal Carcinoma
    • +3 more
    • Aachen, Germany
    • +28 more
    Aug 24, 2023

    Nasopharyngeal Carcinoma, Nasopharyngeal Cancer Trial in China (Cadonilimab, Gemcitabine, Cisplatin)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Nasopharyngeal Cancer
    • Bengbu, Anhui, China
    • +12 more
    Dec 13, 2022

    Nasopharyngeal Carcinoma, Liver Metastases Trial in Shanghai (Hepatectomy)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Liver Metastases
    • Hepatectomy
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Mar 4, 2023

    Nasopharyngeal Tumors Trial in Guangzhou (gemcitabine and cisplatin, 5-Fluorouracil and cisplatin)

    Completed
    • Nasopharyngeal Neoplasms
    • gemcitabine and cisplatin
    • 5-Fluorouracil and cisplatin
    • Guangzhou, Guangdong, China
      Department of Medical Oncology,Cancer Center of Sun Yat-Sen Univ
    Sep 27, 2021

    Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Stanford (VK-2019)

    Recruiting
    • Nasopharyngeal Cancer
    • Epstein-Barr Virus Related Carcinoma
    • Stanford, California
      Stanford University
    Mar 31, 2022

    Chronic Rhinosinusitis (Diagnosis), Nasal Polyposis Trial in Sherbrooke (Budesonide 0.5 MG/ML, Mometasone nasal spray)

    Terminated
    • Chronic Rhinosinusitis (Diagnosis), Nasal Polyposis
    • Budesonide 0.5 MG/ML
    • Mometasone nasal spray
    • Sherbrooke, Quebec, Canada
      Université de Sherbrooke
    Sep 16, 2022

    Familial Adenomatous Polyposis Trial in Bologna (Eicosapentaenoic acid free fatty acid (EPA-FFA), Placebo)

    Recruiting
    • Familial Adenomatous Polyposis
    • Eicosapentaenoic acid free fatty acid (EPA-FFA)
    • Placebo
    • Bologna, Italy
      University of Bologna and St.Orsola-Malpighi Hospital
    Oct 26, 2022

    Familial Adenomatous Polyposis Trial in Marrero, Salt Lake City (REC-4881, Placebo)

    Recruiting
    • Familial Adenomatous Polyposis
    • Marrero, Louisiana
    • +1 more
    Jan 21, 2023

    Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base

    Recruiting
    • Tumors
    • Standard of Care
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 8, 2023

    Familial Adenomatous Polyposis Trial in Amsterdam (Lithium Carbonate)

    Enrolling by invitation
    • Familial Adenomatous Polyposis
    • Lithium Carbonate
    • Amsterdam, Noord-Holland, Netherlands
      Academic Medical Centre
    Jun 22, 2022

    Chronic Rhinosinusitis With Nasal Polyposis Trial (CM310, Placebo)

    Not yet recruiting
    • Chronic Rhinosinusitis With Nasal Polyposis
    • CM310
    • Placebo
    • (no location specified)
    Jun 30, 2022